Richard Delarue
-
- Lymphoma Diagnosis and Treatment 45
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 33
- Oncology top 5%
- Viral-associated cancers and disorders 19
- CAR-T cell therapy research 6
- Neurology top 5%
- CNS Lymphoma Diagnosis and Treatment 6
- Hematology top 5%
-
- Acute Lymphoblastic Leukemia research 8
-
- Photonic and Optical Devices 7
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- G TardieuOlivier HermineCorinne HaïounP.J.R. LaybournHervé TillyNicole BrousseGeorge StewartC. Millar
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Richard Delarue
86 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 110
- Pathology and Forensic Medicine 947
- Genetics 475
- Oncology 734
- Neurology 381
- Hematology 260
Countries citing papers authored by Richard Delarue
This map shows the geographic impact of Richard Delarue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Delarue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Delarue more than expected).
Fields of papers citing papers by Richard Delarue
This network shows the impact of papers produced by Richard Delarue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Delarue. The network helps show where Richard Delarue may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard Delarue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 8 | |
| 3 | 2019 | 20 | |
| 4 | 2017 | 5 | |
| 5 | 2017 | 15 | |
| 6 | 2017 | 14 | |
| 7 | 2015 | 43 | |
| 8 | 2014 | 15 | |
| 9 | 2012 | 21 | |
| 10 | 2012 | 14 | |
| 11 | 2011 | 50 | |
| 12 | 2010 | 35 | |
| 13 | 2009 | 50 | |
| 14 | 90yttrium Ibritumomab Tiuxetan (zevalin) Combined With Beam (z-beam) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed Or Refractory Follicular Lymphoma. a Gela Phase Ii Prospective Study | 2009 | 1 |
| 15 | 2008 | 97 | |
| 16 | 2008 | 54 | |
| 17 | 2006 | 47 | |
| 18 | 2006 | 2 | |
| 19 | 2004 | 99 | |
| 20 | [Electroencephalographic study of retarded children of alcoholic parents; comparison with other groups of normal and retarded children]. | 1952 | 1 |
About Richard Delarue
Richard Delarue is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 91 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (33 papers), Viral-associated cancers and disorders (19 papers), Acute Lymphoblastic Leukemia research (8 papers), Photonic and Optical Devices (7 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (6 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (947 citations), Genetics (475 citations) and Oncology (734 citations). Richard Delarue has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include G Tardieu, Olivier Hermine, Corinne Haïoun, P.J.R. Laybourn, Hervé Tilly, Nicole Brousse, George Stewart, C. Millar, Christopher J. Wilkinson and Bertrand Coiffier.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.